SIRT4 and cancer: In particular, it appears that Sirt4 preserves NAD+ levels through nicotinamide phosphoribosyltransferase (NAMPT) activity [37], while loss of Sirt4 enhances glutamine metabolism, leading to genomic instability and oncogenic phenotype [38], thereby suggesting a protective role of this protein against cancer.